跳至主要内容
临床试验/NCT06656039
NCT06656039已完成不适用

Development and Validation of a Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma: a Multicenter Cohort Study

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,200
试验地点
1
主要终点
Disease free survival

研究概览

简要总结

The main goal of this observational study is to construct a predictive recurrence model for renal clear cell carcinoma through an artificial intelligence multimodal algorithm, which will improve the prognosis and survival time of ccRCC patients by helping clinicians to formulate individualised follow-up and to screen for appropriate adjuvant therapy candidates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with malignant renal tumours must have postoperative pathological confirmation of renal clear cell carcinoma with pathological TNM stage Ⅰ-Ⅲ;
  • Have available preoperative imaging
  • Have available post-operative pathological paraffin samples or HE-stained tissue sections
  • Must agree to and be able to comply with the study's visit schedule and other requirements as specified in the protocol, including follow-up visits by telephone

排除标准

  • The patient's tumour type cannot be determined on the basis of histopathological sections
  • Simultaneous combination of primary tumours at other sites;
  • No regular follow-up imaging data
  • Cases in which other factors led the investigator to believe that enrolment was inappropriate
  • Cases that met all the inclusion criteria of the appeal and did not meet all the exclusion criteria were selected for this study

结局指标

主要结局

Disease free survival

时间窗: "Baseline, immediately after the surgery", "Tumour recurrence or further follow-up", "Three months after surgery", "Six months after surgery", "Every year after surgery, at least follow-up 2years, up to 10 years"

Defined as from surgery to tumor recurrence or follow-up deadline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验